1. Home
  2. DNTH vs PTCT Comparison

DNTH vs PTCT Comparison

Compare DNTH & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

N/A

Current Price

$84.41

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

N/A

Current Price

$56.37

Market Cap

5.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DNTH
PTCT
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.0B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
DNTH
PTCT
Price
$84.41
$56.37
Analyst Decision
Strong Buy
Buy
Analyst Count
18
15
Target Price
★ $139.25
$100.47
AVG Volume (30 Days)
723.8K
★ 939.5K
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 264.48
EPS
N/A
★ 0.34
Revenue
$2,036,000.00
★ $264,734,000.00
Revenue This Year
$22.80
N/A
Revenue Next Year
N/A
$8.29
P/E Ratio
★ N/A
$171.44
Revenue Growth
N/A
★ 36.19
52 Week Low
$35.84
$58.15
52 Week High
$117.88
$90.87

Technical Indicators

Market Signals
Indicator
DNTH
PTCT
Relative Strength Index (RSI) 44.01 33.38
Support Level $79.54 N/A
Resistance Level $91.36 $69.74
Average True Range (ATR) 4.84 2.50
MACD -0.08 -0.78
Stochastic Oscillator 19.24 1.01

Price Performance

Historical Comparison
DNTH
PTCT

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: